Global Kidney Cancer Drug Market Size, Status and Forecast 2018-2025

Published Date : 2018-09-14

Published By : Qy Research Groups

Category : Pharma & Healthcare

No. of Pages : 107

This report focuses on the global Kidney Cancer Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kidney Cancer Drug development in United States, Europe and China.

In 2017, the global Kidney Cancer Drug market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

The key players covered in this study
Active Biotech
Amgen
Bayer AG
Cipla Limited
F. Hoffmann-La Roche
Genentech
Glaxosmithkline PLC
Novartis AG
Onyx Pharmaceuticals
Pfizer
Abbott Laboratories
Aveo Pharmaceuticals
Immatics Biotechnologies
Prometheus Laboratories
Exelixis

Market segment by Type, the product can be split into
Nexavar (Sorafenib)
Sutent (Sunitinib)
Afinitor (Everolimus)
Votrient (Pazopanib)
Avastin (Bevacizumab)
Inlyta (Axitinib),
Torisel (Temsirolimus)
Proleukin (Aldesleukin)
Other

Market segment by Application, split into
Hospitals
Clinics
Research Center
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Kidney Cancer Drug status, future forecast, growth opportunity, key market and key players.
To present the Kidney Cancer Drug development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Kidney Cancer Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Kidney Cancer Drug Market Size Growth Rate by Type (2013-2025)
1.4.2 Nexavar (Sorafenib)
1.4.3 Sutent (Sunitinib)
1.4.4 Afinitor (Everolimus)
1.4.5 Votrient (Pazopanib)
1.4.6 Avastin (Bevacizumab)
1.4.7 Inlyta (Axitinib),
1.4.8 Torisel (Temsirolimus)
1.4.9 Proleukin (Aldesleukin)
1.4.10 Other
1.5 Market by Application
1.5.1 Global Kidney Cancer Drug Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Center
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Kidney Cancer Drug Market Size
2.2 Kidney Cancer Drug Growth Trends by Regions
2.2.1 Kidney Cancer Drug Market Size by Regions (2013-2025)
2.2.2 Kidney Cancer Drug Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Kidney Cancer Drug Market Size by Manufacturers
3.1.1 Global Kidney Cancer Drug Revenue by Manufacturers (2013-2018)
3.1.2 Global Kidney Cancer Drug Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Kidney Cancer Drug Market Concentration Ratio (CR5 and HHI)
3.2 Kidney Cancer Drug Key Players Head office and Area Served
3.3 Key Players Kidney Cancer Drug Product/Solution/Service
3.4 Date of Enter into Kidney Cancer Drug Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Kidney Cancer Drug Market Size by Type (2013-2018)
4.2 Global Kidney Cancer Drug Market Size by Application (2013-2018)

5 United States
5.1 United States Kidney Cancer Drug Market Size (2013-2018)
5.2 Kidney Cancer Drug Key Players in United States
5.3 United States Kidney Cancer Drug Market Size by Type
5.4 United States Kidney Cancer Drug Market Size by Application

6 Europe
6.1 Europe Kidney Cancer Drug Market Size (2013-2018)
6.2 Kidney Cancer Drug Key Players in Europe
6.3 Europe Kidney Cancer Drug Market Size by Type
6.4 Europe Kidney Cancer Drug Market Size by Application

7 China
7.1 China Kidney Cancer Drug Market Size (2013-2018)
7.2 Kidney Cancer Drug Key Players in China
7.3 China Kidney Cancer Drug Market Size by Type
7.4 China Kidney Cancer Drug Market Size by Application

8 Japan
8.1 Japan Kidney Cancer Drug Market Size (2013-2018)
8.2 Kidney Cancer Drug Key Players in Japan
8.3 Japan Kidney Cancer Drug Market Size by Type
8.4 Japan Kidney Cancer Drug Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Kidney Cancer Drug Market Size (2013-2018)
9.2 Kidney Cancer Drug Key Players in Southeast Asia
9.3 Southeast Asia Kidney Cancer Drug Market Size by Type
9.4 Southeast Asia Kidney Cancer Drug Market Size by Application

10 India
10.1 India Kidney Cancer Drug Market Size (2013-2018)
10.2 Kidney Cancer Drug Key Players in India
10.3 India Kidney Cancer Drug Market Size by Type
10.4 India Kidney Cancer Drug Market Size by Application

11 Central & South America
11.1 Central & South America Kidney Cancer Drug Market Size (2013-2018)
11.2 Kidney Cancer Drug Key Players in Central & South America
11.3 Central & South America Kidney Cancer Drug Market Size by Type
11.4 Central & South America Kidney Cancer Drug Market Size by Application

12 International Players Profiles
12.1 Active Biotech
12.1.1 Active Biotech Company Details
12.1.2 Company Description and Business Overview
12.1.3 Kidney Cancer Drug Introduction
12.1.4 Active Biotech Revenue in Kidney Cancer Drug Business (2013-2018)
12.1.5 Active Biotech Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Kidney Cancer Drug Introduction
12.2.4 Amgen Revenue in Kidney Cancer Drug Business (2013-2018)
12.2.5 Amgen Recent Development
12.3 Bayer AG
12.3.1 Bayer AG Company Details
12.3.2 Company Description and Business Overview
12.3.3 Kidney Cancer Drug Introduction
12.3.4 Bayer AG Revenue in Kidney Cancer Drug Business (2013-2018)
12.3.5 Bayer AG Recent Development
12.4 Cipla Limited
12.4.1 Cipla Limited Company Details
12.4.2 Company Description and Business Overview
12.4.3 Kidney Cancer Drug Introduction
12.4.4 Cipla Limited Revenue in Kidney Cancer Drug Business (2013-2018)
12.4.5 Cipla Limited Recent Development
12.5 F. Hoffmann-La Roche
12.5.1 F. Hoffmann-La Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Kidney Cancer Drug Introduction
12.5.4 F. Hoffmann-La Roche Revenue in Kidney Cancer Drug Business (2013-2018)
12.5.5 F. Hoffmann-La Roche Recent Development
12.6 Genentech
12.6.1 Genentech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Kidney Cancer Drug Introduction
12.6.4 Genentech Revenue in Kidney Cancer Drug Business (2013-2018)
12.6.5 Genentech Recent Development
12.7 Glaxosmithkline PLC
12.7.1 Glaxosmithkline PLC Company Details
12.7.2 Company Description and Business Overview
12.7.3 Kidney Cancer Drug Introduction
12.7.4 Glaxosmithkline PLC Revenue in Kidney Cancer Drug Business (2013-2018)
12.7.5 Glaxosmithkline PLC Recent Development
12.8 Novartis AG
12.8.1 Novartis AG Company Details
12.8.2 Company Description and Business Overview
12.8.3 Kidney Cancer Drug Introduction
12.8.4 Novartis AG Revenue in Kidney Cancer Drug Business (2013-2018)
12.8.5 Novartis AG Recent Development
12.9 Onyx Pharmaceuticals
12.9.1 Onyx Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Kidney Cancer Drug Introduction
12.9.4 Onyx Pharmaceuticals Revenue in Kidney Cancer Drug Business (2013-2018)
12.9.5 Onyx Pharmaceuticals Recent Development
12.10 Pfizer
12.10.1 Pfizer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Kidney Cancer Drug Introduction
12.10.4 Pfizer Revenue in Kidney Cancer Drug Business (2013-2018)
12.10.5 Pfizer Recent Development
12.11 Abbott Laboratories
12.12 Aveo Pharmaceuticals
12.13 Immatics Biotechnologies
12.14 Prometheus Laboratories
12.15 Exelixis

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details


List of Tables and Figures

Table Kidney Cancer Drug Key Market Segments
Table Key Players Kidney Cancer Drug Covered
Table Global Kidney Cancer Drug Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Kidney Cancer Drug Market Size Market Share by Type 2013-2025
Figure Nexavar (Sorafenib) Figures
Table Key Players of Nexavar (Sorafenib)
Figure Sutent (Sunitinib) Figures
Table Key Players of Sutent (Sunitinib)
Figure Afinitor (Everolimus) Figures
Table Key Players of Afinitor (Everolimus)
Figure Votrient (Pazopanib) Figures
Table Key Players of Votrient (Pazopanib)
Figure Avastin (Bevacizumab) Figures
Table Key Players of Avastin (Bevacizumab)
Figure Inlyta (Axitinib), Figures
Table Key Players of Inlyta (Axitinib),
Figure Torisel (Temsirolimus) Figures
Table Key Players of Torisel (Temsirolimus)
Figure Proleukin (Aldesleukin) Figures
Table Key Players of Proleukin (Aldesleukin)
Figure Other Figures
Table Key Players of Other
Table Global Kidney Cancer Drug Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Research Center Case Studies
Figure Other Case Studies
Figure Kidney Cancer Drug Report Years Considered
Table Global Kidney Cancer Drug Market Size 2013-2025 (Million US$)
Figure Global Kidney Cancer Drug Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Kidney Cancer Drug Market Size by Regions 2013-2025 (Million US$)
Table Global Kidney Cancer Drug Market Size by Regions 2013-2018 (Million US$)
Table Global Kidney Cancer Drug Market Share by Regions 2013-2018
Figure Global Kidney Cancer Drug Market Share by Regions 2013-2018
Figure Global Kidney Cancer Drug Market Share by Regions 2018
Table Market Top Trends
Table Global Kidney Cancer Drug Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Kidney Cancer Drug Market Share by Manufacturers (2013-2018)
Figure Global Kidney Cancer Drug Market Share by Manufacturers in 2018
Table Global Kidney Cancer Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Kidney Cancer Drug Product/Solution/Service
Table Date of Enter into Kidney Cancer Drug Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Kidney Cancer Drug Market Size by Type (2013-2018) (Million US$)
Table Global Kidney Cancer Drug Market Size Share by Type (2013-2018)
Figure Global Kidney Cancer Drug Market Size Market Share by Type (2013-2018)
Table Global Kidney Cancer Drug Market Size by Application (2013-2018) (Million US$)
Table Global Kidney Cancer Drug Market Size Share by Application (2013-2018)
Figure Global Kidney Cancer Drug Market Size Market Share by Application (2013-2018)
Figure Global Kidney Cancer Drug Revenue Market Share by Application in 2017
Figure United States Kidney Cancer Drug Market Size 2013-2018 (Million US$)
Table United States Key Players Kidney Cancer Drug Revenue (2017-2018) (Million US$)
Table United States Key Players Kidney Cancer Drug Market Share (2017-2018)
Table United States Kidney Cancer Drug Market Size by Type (2013-2018) (Million US$)
Table United States Kidney Cancer Drug Market Share by Type (2013-2018)
Table United States Kidney Cancer Drug Market Size by Application (2013-2018) (Million US$)
Table United States Kidney Cancer Drug Market Share by Application (2013-2018)
Figure Europe Kidney Cancer Drug Market Size 2013-2018 (Million US$)
Table Europe Key Players Kidney Cancer Drug Revenue (2017-2018) (Million US$)
Table Europe Key Players Kidney Cancer Drug Market Share (2017-2018)
Table Europe Kidney Cancer Drug Market Size by Type (2013-2018) (Million US$)
Table Europe Kidney Cancer Drug Market Share by Type (2013-2018)
Table Europe Kidney Cancer Drug Market Size by Application (2013-2018) (Million US$)
Table Europe Kidney Cancer Drug Market Share by Application (2013-2018)
Figure China Kidney Cancer Drug Market Size 2013-2018 (Million US$)
Table China Key Players Kidney Cancer Drug Revenue (2017-2018) (Million US$)
Table China Key Players Kidney Cancer Drug Market Share (2017-2018)
Table China Kidney Cancer Drug Market Size by Type (2013-2018) (Million US$)
Table China Kidney Cancer Drug Market Share by Type (2013-2018)
Table China Kidney Cancer Drug Market Size by Application (2013-2018) (Million US$)
Table China Kidney Cancer Drug Market Share by Application (2013-2018)
Figure Japan Kidney Cancer Drug Market Size 2013-2018 (Million US$)
Table Japan Key Players Kidney Cancer Drug Revenue (2017-2018) (Million US$)
Table Japan Key Players Kidney Cancer Drug Market Share (2017-2018)
Table Japan Kidney Cancer Drug Market Size by Type (2013-2018) (Million US$)
Table Japan Kidney Cancer Drug Market Share by Type (2013-2018)
Table Japan Kidney Cancer Drug Market Size by Application (2013-2018) (Million US$)
Table Japan Kidney Cancer Drug Market Share by Application (2013-2018)
Figure Southeast Asia Kidney Cancer Drug Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Kidney Cancer Drug Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Kidney Cancer Drug Market Share (2017-2018)
Table Southeast Asia Kidney Cancer Drug Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Kidney Cancer Drug Market Share by Type (2013-2018)
Table Southeast Asia Kidney Cancer Drug Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Kidney Cancer Drug Market Share by Application (2013-2018)
Figure India Kidney Cancer Drug Market Size 2013-2018 (Million US$)
Table India Key Players Kidney Cancer Drug Revenue (2017-2018) (Million US$)
Table India Key Players Kidney Cancer Drug Market Share (2017-2018)
Table India Kidney Cancer Drug Market Size by Type (2013-2018) (Million US$)
Table India Kidney Cancer Drug Market Share by Type (2013-2018)
Table India Kidney Cancer Drug Market Size by Application (2013-2018) (Million US$)
Table India Kidney Cancer Drug Market Share by Application (2013-2018)
Figure Central & South America Kidney Cancer Drug Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Kidney Cancer Drug Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Kidney Cancer Drug Market Share (2017-2018)
Table Central & South America Kidney Cancer Drug Market Size by Type (2013-2018) (Million US$)
Table Central & South America Kidney Cancer Drug Market Share by Type (2013-2018)
Table Central & South America Kidney Cancer Drug Market Size by Application (2013-2018) (Million US$)
Table Central & South America Kidney Cancer Drug Market Share by Application (2013-2018)
Table Active Biotech Company Details
Table Active Biotech Revenue in Kidney Cancer Drug Business (2013-2018) (Million US$)
Figure Active Biotech Revenue Growth Rate in Kidney Cancer Drug Business (2013-2018)
Table Active Biotech Recent Development
Table Amgen Company Details
Table Amgen Revenue in Kidney Cancer Drug Business (2013-2018)(Million US$)
Figure Amgen Revenue Growth Rate in Kidney Cancer Drug Business (2013-2018)
Table Amgen Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Kidney Cancer Drug Business (2013-2018)(Million US$)
Figure Bayer AG Revenue Growth Rate in Kidney Cancer Drug Business (2013-2018)
Table Bayer AG Recent Development
Table Cipla Limited Company Details
Table Cipla Limited Revenue in Kidney Cancer Drug Business (2013-2018)(Million US$)
Figure Cipla Limited Revenue Growth Rate in Kidney Cancer Drug Business (2013-2018)
Table Cipla Limited Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Kidney Cancer Drug Business (2013-2018)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Kidney Cancer Drug Business (2013-2018)
Table F. Hoffmann-La Roche Recent Development
Table Genentech Company Details
Table Genentech Revenue in Kidney Cancer Drug Business (2013-2018)(Million US$)
Figure Genentech Revenue Growth Rate in Kidney Cancer Drug Business (2013-2018)
Table Genentech Recent Development
Table Glaxosmithkline PLC Company Details
Table Glaxosmithkline PLC Revenue in Kidney Cancer Drug Business (2013-2018)(Million US$)
Figure Glaxosmithkline PLC Revenue Growth Rate in Kidney Cancer Drug Business (2013-2018)
Table Glaxosmithkline PLC Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Kidney Cancer Drug Business (2013-2018)(Million US$)
Figure Novartis AG Revenue Growth Rate in Kidney Cancer Drug Business (2013-2018)
Table Novartis AG Recent Development
Table Onyx Pharmaceuticals Company Details
Table Onyx Pharmaceuticals Revenue in Kidney Cancer Drug Business (2013-2018)(Million US$)
Figure Onyx Pharmaceuticals Revenue Growth Rate in Kidney Cancer Drug Business (2013-2018)
Table Onyx Pharmaceuticals Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Kidney Cancer Drug Business (2013-2018)(Million US$)
Figure Pfizer Revenue Growth Rate in Kidney Cancer Drug Business (2013-2018)
Table Pfizer Recent Development
Table Abbott Laboratories Company Details
Table Aveo Pharmaceuticals Company Details
Table Immatics Biotechnologies Company Details
Table Prometheus Laboratories Company Details
Table Exelixis Company Details
Table Global Kidney Cancer Drug Market Size by Regions (Million US$) 2018-2025
Figure Global Kidney Cancer Drug Market Size Share by Regions (2018-2025)
Figure Global Kidney Cancer Drug Market Size Share by Regions in 2025
Figure United States Kidney Cancer Drug Market Size Forecast (2018-2025)(Million USD)
Figure Europe Kidney Cancer Drug Market Size Forecast (2018-2025)(Million USD)
Figure China Kidney Cancer Drug Market Size Forecast (2018-2025)(Million USD)
Figure Japan Kidney Cancer Drug Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Kidney Cancer Drug Market Size Forecast (2018-2025)(Million USD)
Figure India Kidney Cancer Drug Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Kidney Cancer Drug Market Size Forecast (2018-2025)(Million USD)
Table Global Kidney Cancer Drug Market Size by Product (2018-2025) (Million US$)
Figure Global Kidney Cancer Drug Market Size by Product (2018-2025)
Figure Global Kidney Cancer Drug Market Size by Product in 2025
Table Global Kidney Cancer Drug Market Size by Application (2018-2025) (Million US$)
Figure Global Kidney Cancer Drug Market Size by Application (2018-2025)
Figure Global Kidney Cancer Drug Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Kidney Cancer Drug  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-236-2744

sales@qyresearchgroups.com